The study population included 240,618 patients with overweight or obesity who were prescribed semaglutide or non-GLP1R agonist anti-obesity medications, with the findings replicated in 1,589,855 patients with T2DM
semaglutide dose (8 and 16 mg) above approved 2 mg, offers weight loss and modest glycemic benefits, but more gastrointestinal side effects, in type 2 diabetes with overweight/obesity
Finally, the samples were prepared for Western blotting analysis by lysing the brain homogenates on ice for 300 minutes in 100 mL of a lysis buffer composed of 120 mM NaCL, 40 mM Tris (pH 8), and 0.1% NP40, followed by centrifugation
Its a great ingredient for brightening, but its become so commonplace as an ingredient in skincare, that its not worth investing in a separate product